A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes

NCT05693909 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Beta Thalassemia Major Anemia
Myelodysplastic Syndrome

Interventions

DRUG: SP-420

Sponsor

Pharmacosmos A/S

Collaborators

[object Object]